Re: TNBC Competition

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4393 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TNBC Competition

in response to

Re: TNBC Competition

KOO-KOO2

posted on Feb 21, 2023 12:10PM

koo, the best reference I can give is the link provided by the CCS in my post. My post was a copy paste from facebook.